CNS TUMOR
Clinical trials for CNS TUMOR explained in plain language.
Never miss a new study
Get alerted when new CNS TUMOR trials appear
Sign up with your email to follow new studies for CNS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for kids with rare cancers
Disease control CompletedThis study tested a drug called avapritinib in 29 children aged 2 to 18 with advanced solid tumors that have specific gene changes (KIT or PDGFRA). The goal was to see if the drug is safe and can shrink tumors. Since these children had no other treatment options, the study aimed …
Matched conditions: CNS TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New Gadolinium-Free MRI dye could make brain scans safer
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…
Matched conditions: CNS TUMOR
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated May 17, 2026 03:12 UTC
-
Brain tumor drug wafers under the microscope: Real-World results revealed
Knowledge-focused CompletedThis study followed 272 adults with brain tumors who received Gliadel wafers (chemotherapy implants) as part of their normal treatment. Researchers tracked how long patients lived, how long until the tumor came back, and any serious side effects. The goal was to see how well the …
Matched conditions: CNS TUMOR
Sponsor: Arbor Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:17 UTC